Five Prime Therapeutics Stock Price (NASDAQ:FPRX)

Add to My Stocks
$30.22 $0.79 (2.55%) FPRX stock closing price Jul 25, 2017 (Closing)
Prev Close* : $31.01
Market Cap:
$892.65M
Day Low: $30.19
52 Week Low: $26.65
Open: $31.12
Volume: 232085
Day High: $31.53
52 Week High: $60.98
Dividend:
N/A

Latest Stock Market News

Latest Articles

Five Prime Therapeutics News - From Partners

FPRX Stockcharts

View FPRX PE ratio, PS ratio stocks charts and compare with peers.
FPRX Chart
Note: Compare Five Prime Therapeutics stock price history with the index and industry peers.

Five Prime Therapeutics Valuation

PS ratio (
price to sales ratio
)
24.36
PB ratio (
price to book ratio
)
2.08

Five Prime Therapeutics Financial Ratios

Asset Turnover
0.1
Receivables Turnover
5.33

FPRX Industry Peers

Company Price Change (%)
Biohaven Pharm (BHVN)26.230.44 (1.71%)
Keryx Biopharma (KERX)7.450.16 (2.19%)
Bristol-myers Squibb (BMY)55.950.35 (0.63%)
Bluebird Bio (BLUE)98.81.05 (1.05%)
Pfizer (PFE)33.10.22 (0.66%)
Glaxosmithkline (GSK)41.960.28 (0.66%)
Eli Lilly (LLY)82.192.55 (3.01%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Compugen (CGEN)4.050.65 (19.12%)
Idera Pharma (IDRA)2.060.14 (7.29%)
Merrimack Pharma (MACK)1.360.05 (3.82%)
PDL BioPharma (PDLI)2.460.08 (3.36%)
Horizon Pharma (HZNP)13.480.32 (2.43%)
Keryx Biopharma (KERX)7.450.16 (2.19%)
Acorda Therapeutics (ACOR)22.850.45 (2.01%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017
CompanyPriceChange (%)
Novavax (NVAX)1.10.41 (27.15%)
Dynavax Technologies (DVAX)9.90.75 (7.04%)
Vital Therapies (VTL)2.650.15 (5.36%)
EXACT Sciences (EXAS)37.332.11 (5.35%)
China Biologic Products (CBPO)98.325.05 (4.89%)
Epizyme (EPZM)12.650.65 (4.89%)
Trevena (TRVN)2.820.14 (4.73%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017

Five Prime Therapeutics Inc Stock News - Partner Headlines

Five Prime Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues30.69M379.8M19.23M13.79M9.98M
Net Income-65.69M249.64M-37.42M-28.87M-27.59M
Total Operating Expense129.9M92.82M56.8M43.2M37.77M
view Five Prime Therapeutics Inc income statement
balance sheet20162015201420132012
Total Assets448.28M548.28M155.63M81.79M44.09M
Total Liabilities56.7M115.07M70.42M23.76M23.68M
Shareholders Equity391.57M433.2M85.2M58.02M20.4M
view Five Prime Therapeutics Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-71.07M36.22M46.18M-0.23M5.42M
Net Cash From (Used By) Operating Activities-79.75M289.09M15.26M-25.33M-18.39M
Increase (Decrease) In Prop Plant And Equipment-2.96M-2.42M-1.64M-0.8M-0.73M
view Five Prime Therapeutics Inc cashflow statement

Five Prime Therapeutics Stock Message Board

Five Prime Therapeutics stock price ended the last trading day at 30.22. Looking at Five Prime Therapeutics market capitalization, which currently stands at 892.65M, we can say that FPRX stock is a Small cap stock. Five Prime Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

Demand for a stock decides its stock market price. For example, if more investors want to buy FPRX stock than sell it, then Five Prime Therapeutics stock price goes up. Conversely, if more investors wanted to sell FPRX stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Five Prime Therapeutics stock quote data shows the number of shares traded. For Ex: 232085 Five Prime Therapeutics shares were traded as of last trading day, as seen from Five Prime Therapeutics stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Five Prime Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.